Data as of 10:53am ET
| +0.98 / +2.53%|
The 3 analysts offering 12-month price forecasts for Furiex Pharmaceuticals Inc have a median target of 52.00, with a high estimate of 57.00 and a low estimate of 47.00. The median estimate represents a +31.15% increase from the last price of 39.65.
The current consensus among 4 polled investment analysts is to Buy stock in Furiex Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.